Mitoquinone mesylate as post-exposure prophylaxis against SARS-CoV-2 infection in humans: an exploratory single center pragmatic open label non-randomized pilot clinical trial with matched controls

By sjmartinez • March 12, 2024

Chen K, Jackson NJ, Kelesidis T. Mitoquinone mesylate as post-exposure prophylaxis against SARS-CoV-2 infection in humans: an exploratory single center pragmatic open label non-randomized pilot clinical trial with matched controls. EBioMedicine. 2024 Mar 7:105042. doi: 10.1016/j.ebiom.2024.105042. Epub ahead of print. PMID: 38471990.

Tags: Antiviral treatment, clinical trials, covid-19, General Internal Medicine, Mitochondrial antioxidants, Post-exposure prophylaxis, Publications, SARS-CoV-2 infection, Translational research

Sustained Reduction of Elevated Intact Parathyroid Hormone Concentrations with Extended-Release Calcifediol Slows Chronic Kidney Disease Progression in Secondary Hyperparathyroidism Patients

Bishop CW, Ashfaq A, Strugnell SA, Choe J, Patel N, Norris KC, Sprague SM. Sustained Reduction of Elevated Intact Parathyroid Hormone Concentrations with Extended-Release Calcifediol[...]

Practice Pattern and Outcome Differences in the Emergency Department by Physician Sex

Ly DP, Coussens S, Burke LG. Practice Pattern and Outcome Differences in the Emergency Department by Physician Sex. JAMA Intern Med. 2026 Jul 20. doi:[...]

Gender-Based Differences in Arthroplasty Utilization Across Two Tertiary Academic Centers

Mefford MR, Wahle CF, Grellinger ED, Chi H, Newman-Hung NJ, Woolley KA, Dlott C, Jackson NJ, Wong SE, Stavrakis AI, Wessel LE. Gender-Based Differences in[...]